Medicine and Dentistry
Deep Brain Stimulation
100%
Gamma Knife Radiosurgery
58%
Brain Metastasis
54%
Parkinson's Disease
39%
Metastatic Carcinoma
36%
Overall Survival
32%
Infection
31%
Multivariate Analysis
27%
Karnofsky Performance Status
27%
Stereotactic Radiosurgery
24%
Prognostic Factor
23%
Retrospective Study
23%
Clear Cell Renal Cell Carcinoma
22%
Lung
22%
Fistula
21%
Neoplasm
21%
Pallidotomy
19%
Dural Arteriovenous Fistula
19%
Volume CT
19%
Brainstem
19%
Glioblastoma
19%
Metastatic Melanoma
19%
Breast Cancer
19%
Vein Blood Flow
19%
Frameless Stereotactic Procedure
19%
Adenocarcinoma
19%
Computer Assisted Tomography
19%
Solitary Fibrous Tumor
19%
Venography
19%
Granuloma
19%
Odds Ratio
19%
Essential Tremor
19%
Parageusia
19%
Melanoma
18%
Whole Brain Radiotherapy
15%
Salvage Therapy
11%
Median Survival Time
11%
Magnetic Resonance Imaging
11%
Operating Room
10%
Recurrent Disease
10%
Stereotypic Movement Disorder
9%
Subthalamic Nucleus
9%
Globus pallidus
9%
Unified Parkinson's Disease Rating Scale
9%
Cerebral Hemorrhage
8%
Radiation Response
7%
Logistic Regression Analysis
7%
Body Mass Index
7%
Adverse Outcome
7%
Progression Free Survival
7%
Neuroscience
Rostral Ventromedial Medulla
78%
Deep Brain Stimulation
78%
Parkinson's Disease
52%
Pallidotomy
39%
Cholinergic
34%
Nociception
34%
Subthalamic Nucleus
32%
Magnetic Resonance Imaging
29%
2-Deoxy-D-Glucose
23%
Optic Tract
22%
Globus pallidus
20%
Glioblastoma Multiforme
19%
Machine Learning Algorithm
19%
Peripheral Nerve Injury
19%
Adenosine Triphosphate
19%
Intellectual Disability
19%
Positron Emission Tomography
19%
Oxidopamine
19%
Pedunculopontine Nucleus
19%
Fluorine-18
19%
Radiation Therapy
19%
Midbrain Tegmentum
18%
Ansa Lenticularis
14%
Metabolic Pathway
14%
Internal Capsule
12%
Neuronal Activity
9%
Adjuvant Therapy
9%
Receptor Agonists
9%
Adenosine Receptor
9%
Gyri
9%
Basal Ganglia
9%
Hyperalgesia
8%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Dehydrogenase
8%
Staining Technique
8%
Neuropathic Pain
8%
Nerve Injury
8%
Body Mass Index
7%
Computed Tomography
7%
Electrotherapy
6%
Bevacizumab
6%
Cell Activation
6%
Receptor Antagonist
6%
P2Y Receptor
6%
Purinergic P2X Receptor
6%
Adenosine
6%
Intracranial Tumor
6%
Stereotypic Movement Disorder
6%
Allodynia
5%
Firing Rate
5%
Spinal Nerve
5%
Nursing and Health Professions
Electrical Brain Stimulation
39%
Parkinson's Disease
23%
Glioblastoma
19%
Odds Ratio
19%
Postoperative Delirium
19%
Gamma Knife Radiosurgery
19%
Confidence Interval
19%
Clinical Outcome
19%
Area under the Curve
19%
Delirium
19%
Overall Survival
11%
Salvage Therapy
11%
Logistic Regression Analysis
7%
Adverse Outcome
7%
Cancer Control
7%
Radiation Response
7%
Progression Free Survival
7%
Recurrent Disease
7%
Operating Room
7%
Body Mass
7%